Cost-minimization Analysis of 4 Chemotherapies for Advanced (Ⅲb～Ⅳ) Non-small Cell Lung Cancer
- VernacularTitle:4种化疗方案治疗Ⅲb～Ⅳ期非小细胞肺癌的最小成本分析
- Author:
Hong GUO
;
Hong XU
;
Xiuming ZHANG
;
Wenjing LI
- Publication Type:Journal Article
- Keywords:
Non-small cell lung cancer;
Chemotherapy;
Cost-minimization analysis
- From:
China Pharmacy
2005;0(14):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05),respectively.The adverse drug reactions(ADR)were characterized by different degree of myelosuppression,change in platelet,nausea and vomiting,alopecia etc,all were cured with symptomatic treatment.CONCLUSION:NP scheme enjoys good cost-effectiveness,but with severe ADR.For those patients had good economical condition and attach great importance to life quality,GP scheme is preferable.
